Skip to main content
. 2017 Oct 19;4(1):e000242. doi: 10.1136/bmjresp-2017-000242

Table 4.

Suggested antibiotic regimen for adults with Mycobacterium kansasii-pulmonary disease

M. kansasii-pulmonary disease Antibiotic regimen
Rifampicin-sensitive M. kansasii-pulmonary disease Rifampicin 600 mg daily
and
Ethambutol 15 mg/kg daily
and
Isoniazid 300 mg (with pyridoxine 10 mg) daily or azithromycin 250 mg daily or clarithromycin 500 mg twice daily.
Antibiotic treatment should continue for a minimum of 12 months after culture conversion.